References
- Adkison JB, Khuntia D, Bentzen SM, . Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: Preliminary results of a risk-stratified phase I dose escalation study. Technol Cancer Res Treat 2008;7:441–7.
- Song CH, Pyo H, Moon SH, Kim TH, Kim DW, Cho KH. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy. Int J Radiat Oncol Biol Phys 2010;78:651–8.
- Vogelius IS, Westerly DC, Cannon GM, Mackie TR, Mehta MP, Sugie C, Bentzen SM. Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: A modeling study of dose dumping. Int J Radiat Oncol Biol Phys In Press, Corrected Proof, Available online 7 April 2011, ISSN 0360-3016, DOI: 10.1016/j.ijrobp.2010.12.073.(http://www.sciencedirect.com/science/article/B6T7X-52JWFGR-B/2/73278d0755c82c2304ee811cdbb234d4).
- Nystrom H. The role of protons in modern and biologically-guided radiotherapy. Acta Oncol 2010;49:1124–31.
- Vogelius IS, Westerly DC, Cannon GM, Bentzen SM. Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques. Acta Oncol 2010;49:1052–7.
- Jackson A, Kutcher GJ, Yorke ED. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys 1993; 20:613–25.
- Niemierko A, Goitein M. Modeling of normal tissue response to radiation: The critical volume model. Int J Radiat Oncol Biol Phys 1993;25:135–45.
- Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CC. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 2005;63:672–82.
- Bentzen SM, Overgaard M, Thames HD, Christensen JJ, Overgaard J. Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Biol 1989;56:711–5.
- Moyers MF, Miller DW, Bush DA, Slater JD. Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys 2001;49:1429–38.
- Engelsman M, Kooy HM. Target volume dose considerations in proton beam treatment planning for lung tumors. Med Phys 2005;32:3549–57.
- af Rosenschold PM, Aznar MC, Nygaard DE, . A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer. Acta Oncol 2010;49:1141–8.
- Knopf A, Bert C, Heath E, . Special report: Workshop on 4D-treatment planning in actively scanned particle therapy – recommendations, technical challenges, and future research directions. Med Phys 2010;37:4608–14.